In this study, the structural parameters and inhibitory potential of specific organotin(IV) compounds, with and without the SBA-15~Cl carrier, were evaluated against key enzymes involved in the pathophysiology of Alzheimer’s disease: AChE, COMT, and MAO-B (Figure 1). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.